B
BioBoss
David Southwell: CEO of Volastra Therapeutics
Episode 88
0:00-31:26
David Southwell, CEO of Volastra Therapeutics, shares his insights about leadership in biopharma and how Volastra is working to discover and develop oncology therapeutics targeting chromosomal instability, a vulnerability of cancers.
Publisher
BioBoss
Link
wyantsimboli.com/bioboss/david-southwell-ceo-of-volastra-therapeutics
Published
February 28, 2026
Duration
31 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
John Simboli
B
BioBoss
@bioboss
#davidsouthwell #volastratherapeutics #lifesciences #investing
